Cite

HARVARD Citation

    Sandborn, W. et al. (n.d.). Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States. Current medical research and opinion. pp. 1233-1241. [Online]. 
  
Back to record